Internal Medicine, Infectious Disease · Philadelphia, PA
NPI
1205823127
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3401 N Broad St
Philadelphia, PA, 19140
Phone (215) 707-3807
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
360 services
Medicare patients, 2024
169
Average age 69
Drug cost, 2024
$348K
754 prescriptions
Company payments, 2025
$7.29
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter Axelrod was code 99232 (hospital e&m - subsequent), 113 times for 58 patients. In total Peter Axelrod billed 360 services in 18 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 113 | 58 | $63.78 | $7,207 |
| 99222 Hospital E&M - Initial | Facility | 62 | 59 | $105.65 | $6,550 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 30 | $13.37 | $521 |
| 99215 Office E&M - Established | Office | 25 | 18 | $147.95 | $3,699 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $140.38 | $3,369 |
| 99233 Hospital E&M - Subsequent | Facility | 22 | 18 | $96.07 | $2,114 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 14 | 14 | $13.37 | $187 |
| 99205 Office E&M - New | Office | 13 | 13 | $167.35 | $2,176 |
By year: 2022 $20K for 219 services; 2023 $27K for 277 services; 2024 $30K for 360 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter Axelrod prescribed most often to Medicare patients was Azithromycin, with 44 prescriptions and refills. In total Peter Axelrod wrote 754 Medicare prescriptions that cost $348K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 44 | 53 | 11 | $1,037 |
| Levofloxacin Generic | 29 | 29 | 17 | $370 |
| Ciprofloxacin Hcl Generic | 29 | 31 | 12 | $155 |
| Ondansetron Hcl Generic | 26 | 32 | Under 11 | $75.52 |
| Gabapentin Generic | 26 | 28 | Under 11 | $443 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 25 | 35 | Under 11 | $360 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 24 | 29 | 14 | $1,073 |
| Rifabutin Generic | 21 | 25 | Under 11 | $11K |
| Fluconazole Generic | 21 | 23 | Under 11 | $609 |
| Cefuroxime Cefuroxime Axetil | 21 | 26 | 12 | $765 |
| Ethambutol Hcl Generic | 20 | 24 | Under 11 | $1,219 |
| Prednisone Generic | 19 | 23 | Under 11 | $72.08 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 18 | 26 | 11 | $274 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 17 | 17 | Under 11 | $99K |
| Clarithromycin Generic | 17 | 19 | Under 11 | $429 |
Brand drugs: - claims; generic drugs: 636 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter Axelrod $7.29 ($7.29 in general payments such as food, travel and fees) from 1 company. The largest payer was ADMA BioManufacturing LLC with $7.29.
| Company | Payments | Amount |
|---|---|---|
| ADMA BioManufacturing LLC | 1 | $7.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.